Philip McMillan — SPARQNOW

At-a-Glance

Serves as a physician and Lead COVID Autoimmune Researcher.
Proposed in April 2020 that severe COVID-19 represents a viral-mediated autoimmune process involving ACE-2, a hypothesis later published and supported by independent findings.
Focuses on identifying where clinical AI fails quietly when deployed into post-COVID populations.
Conducts research in dementia and neuroinflammation, including publications and international keynote lectures across the UK, Europe, North America, and Asia.

Biography

Philip McMillan is a physician and researcher with three decades of clinical experience across complex disease systems, including stroke, dementia, and immune-mediated pathology. His work centers on the intersection of clinical biology, system behavior, and real-world deployment risk, particularly concerning AI in healthcare.